Mesa Nilda
SEC Form 4 insider trading activity
Mesa Nilda has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Mesa Nilda is listed as Director at UNITED THERAPEUTICS Corp. Inside the rolling window, Mesa Nilda reported no open-market purchases and 3 open-market sales totaling $356K in UTHR. The largest disclosed transaction in the window is a sale of 258 UTHR shares on May 12, 2026, worth $150K.
Companies traded
Other insiders at UTHR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$356K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mesa Nilda made?
Mesa Nilda has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Mesa Nilda trade?
Mesa Nilda has filed SEC Form 4 disclosures for 1 company, including UTHR.
When was Mesa Nilda's most recent SEC Form 4 filing?
Mesa Nilda's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Mesa Nilda's total buy and sell value in the current window?
Inside the rolling retention window, Mesa Nilda bought $0 and sold $356K based on SEC Form 4 filings.
What was Mesa Nilda's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 258 UTHR shares on 2026-05-12, worth $150K, per SEC Form 4 filings.